InfuSystem Announces Master Service Agreement with World’s Leading Health Technology and Diagnostics Company

InfuSystem Holdings, Inc. The National Association of Healthcare Professionals, a leading provider of healthcare solutions to durable medical device manufacturers and healthcare providers, announced today that it has signed a three-year agreement with global healthcare companies and research institutes. April 25, 2022.

As part of the master service agreement, InfuSystem will provide its biomedical services, which include annual preventive maintenance and repairs, on many of the infusion sets for hospitals and other healthcare facilities under contract with a global healthcare company. The site is operated by a major management company or locally outside one of the seven InfuSystem service centers. Global medical technology and research institutes of consumer choice infusion pump ships have more than 300,000 pumps in 1,200 hospitals, including 800 hospital systems in the United States and Canada. It is estimated that the proposed national service agreement will provide between US$10 million and US$12 million after the initial upgrade period and annual revenue from InfuSystem’s DME service platform.

“I am very pleased to announce that InfuSystem has been assigned as a national service provider to a global healthcare company. We will provide our ‘glove-white’ biomedical service for their infusion pump in North America. This master agreement may also provide additional opportunities to serve these customers.” to provide other products and services that we offer under our DME service area. Our portfolio of industry leaders as well as our national network is a key factor in their decision to work with InfuSystem.

 “This challenging management opportunity is the result of our well-coordinated approach to our biomedical services and the creation of a well-functioning customer service department to drive growth and expand market share. Our authorized biomedical team is deployed across North America to begin boarding the global healthcare industry’s infusion ship and work on on-site repairs or at one of our national facilities. I believe this attractive national service agreement lays the foundation for the long-term growth of our DME business as well as for greater expansion of oversight.

“This master agreement represents an important milestone for the company. It is a testament to the hard work and dedication of our team in providing industry-leading solutions and repair solutions. We look forward to long-term and prosperous relationships for years to come,” concluded Mr. DiIorio.

History of InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc. is a national healthcare provider that provides patient care to medical device manufacturers and healthcare providers. INFU services are offered under two platform types. The leading platform is Integrated Therapy Services (“ITS”), which offers the ultimate home healthcare solution, where advanced treatment incorporates robust medical applications and services. ITS departments include oncology, pain management, wound care, and lymphedema business. The second platform, the Permanent Drug Service (“DME Service”), supports the ITS platform and enables robust operations to drive business growth through paying customers. DME services include low-cost rentals, pickup and sale, and biomedical and maintenance services. Headquartered in Rochester Hills, Michigan, the company provides local customer support and operates centers of excellence in Michigan, Kansas, California, Massachusetts, Texas, and Ontario, Canada.